Orange Book product · Brand (NDA)
ARALEN
CHLOROQUINE PHOSPHATE
At a glance
Approved Prior to Jan 1, 1982
Approved
Brand (NDA)
Application
Not listed
TE code
None
Listed patents
Key dates
No patent or exclusivity dates are listed for this product.
Pharmaceutical detail
Active ingredient
CHLOROQUINE PHOSPHATE
Strength
500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Dosage form
TABLET
Route
ORAL
TE code
Not listed
Application
NDA 006002
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
Yes
Reference standard (RS)
No
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
- 2021CHLOROQUINE PHOSPHATEGeneric (ANDA)
ANDA 214756 · SUVEN PHARMS
- 2011CHLOROQUINE PHOSPHATEGeneric (ANDA)
ANDA 091621 · NATCO PHARMA LTD
- 2011CHLOROQUINE PHOSPHATEGeneric (ANDA)
ANDA 090612 · NATCO PHARMA LTD
- 2009CHLOROQUINE PHOSPHATEGeneric (ANDA)
ANDA 090610 · IPCA LABS LTD
- 2009CHLOROQUINE PHOSPHATEGeneric (ANDA)
ANDA 090249 · IPCA LABS LTD
- 2003CHLOROQUINE PHOSPHATEGeneric (ANDA)
ANDA 040516 · IMPAX LABS
- 1982CHLOROQUINE PHOSPHATEGeneric (ANDA)
ANDA 087979 · WATSON LABS
- 1982CHLOROQUINE PHOSPHATEGeneric (ANDA)
ANDA 088030 · WATSON LABS
- 1982CHLOROQUINE PHOSPHATEGeneric (ANDA)
ANDA 087504 · TEVA
- —CHLOROQUINE PHOSPHATEGeneric (ANDA)
ANDA 083082 · HIKMA PHARMS
- —CHLOROQUINE PHOSPHATEGeneric (ANDA)
ANDA 080880 · IMPAX LABS
- —CHLOROQUINE PHOSPHATEGeneric (ANDA)
ANDA 087228 · MD PHARM
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
